Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Vehicle to Methylprednisolone Aceponate Ointment, Methylprednisolone Aceponate Ointment, Advantanยฎ 0,1% Salbe
Alphapharm Pty Ltd
Mild to moderate atopic dermatitis
1 trial -
Volasertib, low dose, d1q3w
Boehringer Ingelheim
Neoplasms
1 trial -
Vonoprazan ODT-1 or ODT-2 without Water
Phathom Pharmaceuticals
Healthy Volunteers
1 trial -
Vyxeos 44 MG / 100 MG Liposome Injection
Jazz Pharmaceuticals Ireland Limited
Relapsed Pediatric AML
1 trial -
Vyxeos Liposomal 44 mg/100 mg powder for concentrate for solution for infusion., Evoltra 1 mg/ml concentrate for solution for infusion
AXIM BIOTECHNOLOGIES, INC.
AML
1 trial -
WGc-0201 injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma (HCC)
1 trial -
WP1122
Moleculin Biotech
Healthy Volunteer
1 trial -
WP1220
Moleculin Biotech
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
1 trial -
WSK-IM05 (4ร10^10 vp)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HPV-positive Oropharyngeal Squamous Cell Carcinoma
1 trial -
WT1-loaded CBDC Vaccine
AXIM BIOTECHNOLOGIES, INC.
AML: Acute Myeloid Leukemia/ cancer of blood and bone marrow
1 trial -
WT1-sensitized T cells
Evidence Based Cataract Study Group
Leukemia
1 trial -
WTX-124
Werewolf Therapeutics
Metastatic Solid Tumor
1 trial -
WX-UK1 in combination with Capecitabine
United Therapeutics Europe Ltd
Advanced Malignancies
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Melanoma
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Healthy
1 trial -
XEN901
Xenon Pharmaceuticals
Healthy Volunteers
1 trial -
XM17
Teva Pharma GmbH
Bioequivalence
1 trial -
XPF-001
Xenon Pharmaceuticals
Healthy Human Volunteers
1 trial -
XTL-2125
XTL BIOPHARMACEUTICALS LTD
Chronic Hepatitis C Virus Infection
1 trial -
XeriSol glucagon
Xeris Biopharma Holdings
Type1diabetes
1 trial -
Y150
Wuhan YZY Biopharma Co.,
Relapsed or Refractory Multiple Myeloma
1 trial -
YB-1113
BRIGHT MINDS BIOSCIENCES INC.
POI
1 trial -
YM178
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Chinese Volunteers
1 trial -
YMN-A02 100ฮผg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources